Growth Metrics

LifeMD (LFMD) Equity Ratio (2016 - 2025)

LifeMD's Equity Ratio history spans 14 years, with the latest figure at 0.33 for Q4 2025.

  • For Q4 2025, Equity Ratio rose 431.29% year-over-year to 0.33; the TTM value through Dec 2025 reached 0.33, up 431.29%, while the annual FY2025 figure was 0.33, 431.29% up from the prior year.
  • Equity Ratio reached 0.33 in Q4 2025 per LFMD's latest filing, up from 0.05 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.47 in Q1 2022 to a low of 3.2 in Q1 2025.
  • Average Equity Ratio over 5 years is 0.25, with a median of 0.04 recorded in 2022.
  • Peak YoY movement for Equity Ratio: soared 1152.97% in 2022, then tumbled 8320.94% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.43 in 2021, then plummeted by 206.37% to 0.46 in 2022, then soared by 115.49% to 0.07 in 2023, then crashed by 238.59% to 0.1 in 2024, then soared by 431.29% to 0.33 in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Equity Ratio are 0.33 (Q4 2025), 0.05 (Q3 2025), and 0.03 (Q2 2025).